arrow
D

Danilo Perrotti

University System of Maryland
H指数:62
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia (vol 35, pg 2285, 2021)

细胞质DROSHA和MiR-155生物发生中非经典机制在FLT3-ITD急性髓系白血病中的作用(卷35,页2285,2021)

LEUKEMIA
IF13.4
2025-05-050
PRE
Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML

治疗诱导的骨髓微环境中小动脉再血管化与miR‑126表达上调共同保护急性髓系白血病中的白血病干细胞

2021-08-0915
OAAI
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
2020-07-0131
OA
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms

精准免疫疗法,突变景观和新兴工具可优化经典骨髓增殖性肿瘤患者的临床结局

2018-08-033
OAAI
The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance
2018-07-010
PRE
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
2018-03-05113
OAAI
Role of the MSC-derived exosomal and endogenous JAK2-SET/PP2A-β-catenin-modulator miR-300 in leukemic stem/progenitor proliferation and survival in CML
2016-07-150
PRE
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia
LEUKEMIA
IF13.4
2015-05-1469
OAAI